Ghent, Belgium / Lausanne, Switzerland – May 19, 2025 – BIO INX and Readily3D proudly announce the launch of READYPCL INX, the world’s first commercially available polyester-based resin for volumetric bioprinting. This innovation marks a significant milestone in the advancement of next-generation bioprinting materials and further cements the collaboration between the two pioneering companies.

A breakthrough in high-resolution 3D bioprinting with the use of DEGRAD INX U100, the world’s first polyester-based biodegradable resin, in a pioneering new two-photon polymerization (2PP) system. This revolutionary technology, developed in the research group led by prof. Aleksandr Ovsianikov at TU Wien, has set a new benchmark as the fastest high resolution 3D printer ever!

A groundbreaking study published in APL Bioengineering demonstrates how advanced 3D bioprinting can revolutionize cancer research by providing realistic in vitro models to study tumor invasion. The research, led by Federico Cantoni and colleagues, of the Maria Tenje Lab at Uppsala University showcases the use of multiphoton lithography to fabricate hydrogel scaffolds that mimic the ECM.